Mandate

Vinge advised Equinor in connection with its investment in Medfield Diagnostics

November 21, 2018 Capital Markets and Public M&A

Vinge advised Equinor Technology Ventures AS (”Equinor”) in connection with its acquisition in Medfield Diagnostics Aktiebolag (publ) (“Medfield”).

The investment will be made through a directed issue to Equinor as well as a rights issue of shares. Medfield is listed on Spotlight.
Equinor ASA is a global energy company with more than 20,000 employees and business in more than 30 countries. Equinor is the largest oil and gas operator in Norway, one of the largest offshore operators globally and has a growing portfolio of renewable assets in wind and solar power.

Equinor Technology Ventures AS invests in technology companies with major implementation potential in the company’s core business. Since its establishment, ETV has invested in more than 60 companies and financed over 260 product developments.

Vinge’s team consisted of Dain Hård Nevonen, Peter Sundgren, Rikard Lindahl, Amanda Knutsson and Peter Issa. 

Related

Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme

Vinge has advised Röko AB (publ) ("Röko") on the establishment of a medium-term note programme (the "MTN Programme") with a framework amount of SEK 5 billion.
November 13, 2026

Vinge advises Telavox on the sale of its Nordic customer base to Telia

Vinge has advised Telavox AB (“Telavox”) on the sale of Telavox’s Nordic customer base for business services to Telia Company AB (“Telia”). The customer base comprises approximately 24,000 business customers and 325,000 end users in Sweden, Denmark, Finland, and Norway. The purchase price amounts to SEK 3.8 billion plus a potential additional earn-out.
November 13, 2026

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026